GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 113,656 shares of the company’s stock after selling 897 shares during the period. Calamos Advisors LLC’s holdings in GE HealthCare Technologies were worth $8,788,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. First Command Advisory Services Inc. increased its position in GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after purchasing an additional 369 shares during the last quarter. Pin Oak Investment Advisors Inc. acquired a new stake in GE HealthCare Technologies during the second quarter worth about $25,000. Legacy Financial Group LLC acquired a new stake in GE HealthCare Technologies during the third quarter worth about $26,000. OFI Invest Asset Management acquired a new stake in GE HealthCare Technologies during the third quarter worth about $26,000. Finally, Resources Management Corp CT ADV acquired a new stake in shares of GE HealthCare Technologies during the second quarter valued at about $28,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 0.6 %

NASDAQ GEHC opened at $84.49 on Friday. The firm has a 50 day simple moving average of $88.74 and a 200-day simple moving average of $77.82. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The firm has a market cap of $38.56 billion, a price-to-earnings ratio of 27.98, a PEG ratio of 2.96 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the previous year, the firm earned $1.31 earnings per share. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Analyst Upgrades and Downgrades

GEHC has been the subject of a number of recent analyst reports. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Mizuho lifted their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Argus lifted their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Finally, Morgan Stanley lifted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.